Interestingly, this dual effect is known to be associated with different Smad3 phosphorylation sites8, 21, 22, 23; however, there have been few reports on the role of domain‐specific Smad3 phosphorylation in the development of liver disease, and the underlying mechanism also remains to be explored. Here, SMAD3 is linked to liver disorder.